About - WHWK :

Whitehawk Therapeutics Inc operates as a clinical-stage biopharmaceutical company. The Company develops precision therapies for genetically-defined cancers.

Employees - 40, CEO - Dr. David J. Lennon Ph.D., Sector - Healthcare, Country - US, Market Cap - 93.74M

Altman ZScore(max is 10): 2.57, Piotroski Score(max is 10): 5, Working Capital: $220340000, Total Assets: $234002000, Retained Earnings: $-259637999, EBIT: -59850000, Total Liabilities: $12274000, Revenue: $27775000

- Current Price $1.99 - Analyst Target Price $2.00

Stats & Key Metrics
TickerWHWK
Index-
Curent Price 1.99
Change13.07%
Market Cap93.74M
Average Volume157.68K
Income27.61M
Sales27.77M
Book Value/Share4.74
Cash/Share4.90
Dividend Est-
Dividend TTM-
Dividend Ex-Date-
Employees40
Moving Avg 20days21.92%
Moving Avg 50days15.01%
Moving Avg 200days-6.95%
Shares Outstanding46.78M
Earnings DateMay 08 AMC
Inst. Ownership48.88%
Key Ratios & Margins
Price/Earnings13.27
Forwad P/E-
PE Growth2.02
Price/Sales3.38
Price/Book0.42
Price/Cash0.41
Price/FCF-
Quick Ratio18.95
Current Ratio18.95
Debt/Equity0.00
Return on Assets16.00%
Return on Equity17.69%
Return on Investment12.45%
Gross Margin88.72%
Ops Margin-217.92%
Profit Margin99.42%
RSI69.74
BETA(β)0.55
From 52week Low64.46%
From 52week High-47.80%
Earnings & Valuation
EPS0.15
EPS next Year-1.89
EPS next Qtr0.49
EPS this Year107.49%
EPS next 5 Year6.57%
EPS past 5 Year22.81%
Sales past 5 Year246.60%
EPS Y/Y106.40%
Sales Y/Y16.51%
EPS Q/Q369.77%
Sales Q/Q33.48%
Sales Surprise-
EPS Surprise497.83%
ATR(14)0.14
Perf Week20.61%
Perf Month28.39%
Perf Quarter-30.66%
Perf Year3.92%
Perf YTD-36.93%
Target Price2.00

AryaFin Engine© - An AI FinTech Venture - 2024-25 Disclaimer